About
About Avecho
Board & Leadership
TPM
®
Technology
Portfolio
Pipeline
Phase III Trial
Cannabinoids
Pharmaceutical
Animal Health
Manufacturing
Invest
Investor Centre
Media Centre
Contact
Hit enter to search or ESC to close
Change of Company Name and ASX Code
May 24, 2019
August 28, 2019
Click here to read more
Post navigation
Previous Post
2019 Annual General Meeting Results
Next Post
Ashland Purchases Manufacturing Rights for VitalET and TPM
Related Posts
Ethics Approval for amendments to Phase III Clinical Trial
March 7, 2024
March 7, 2024
Phosphagenics Completes Grower/Finisher Pig Study
June 30, 2016
Phosphagenics’ PHN Trial Completes Enrolment and Dosing
December 17, 2015